AstraZeneca PLCAZN:LSE

4,120.5
101.50 / 2.53%
3.34m
5.70 %
0.5252
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jul 01 2015 17:15 BST.

Summary

AstraZeneca PLC (AZN:LSE) set a new 52-week low during Tuesday's trading session when it reached 4,019. Over this period, the share price is down 6.74 %.

52-week range
Today
4,019
Jun 30 2015
4,931.68
Apr 22 2015
Markit short selling activity
Low
Medium
High
Open4,062.5
Day high4,141
Day low4,031
Bid4,020
Offer4,200
Previous close4,019
Average volume2.89m
Shares outstanding1.26bn
Free float1.26bn
P/E (TTM)62.55
Market cap50.89bn GBP
EPS (TTM)0.6438 GBP
Annual div (IAD)178.10 GBX
Annual div yield (IAD)4.35%
Div ex-dateFeb 19 2015
Div pay-dateMar 23 2015
Data delayed at least 15 minutes, as of Jul 01 2015 17:15 BST.
Last IC View
The last IC recommendation on AstraZeneca PLC shares was Hold at 4,598 on 06 Feb 2015
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
AstraZeneca PLC-3.05 %-5.63 %-9.55 %-5.70 %+33.22 %
FTSE 100 IDX-3.45 %-4.96 %+0.65 %-2.86 %+37.51 %
GB/HEALTH CARE-2.92 %-7.14 %-2.33 %-6.03 %+32.13 %
GB/PHARMACEUTICALS-2.99 %-7.21 %-1.92 %-6.73 %+31.33 %
Data delayed at least 15 minutes, as of Jul 01 2015 17:15 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.